Botanical species · safety record

Oplopanax horridus

The EFSA Compendium of Botanicals holds 8 constituent measurements for Oplopanax horridus. This page reports what those source records contain and how to reach them. It carries no effect estimate, no dose and no recommendation.

Accepted name in source: Oplopanax horridus (Sm.) Miq.

8Constituent measurements

0Safety records

4Cited sources

1Licensed products (Canada)

Regulatory presence

Health Canada's Licensed Natural Health Products Database holds 1 licensed products naming Oplopanax horridus as a medicinal ingredient, matched on the exact Latin binomial. A licence records that a product met the regulator's requirements for sale in Canada. It is not evidence that the product works.

Source material stated

Root bark

What the records describe

Constituents measured

Plant parts

Preparations

Recorded constituents

What analytical work has found in this species, at which plant part and preparation. A measured constituent is a fact about material, not about effect.

Substance	Plant part	Preparation	Concentration	Analytical method	Source
Falcarindiol	Roots and other underground parts	Solvent extraction	≥ 2.6 Milligram/gram	High Performance Liquid Chromatography (HPLC)/Liquid Chromatography (LC)	Resolve DOI
Falcarindiol	Roots and other underground parts	Super-critical gas extraction	3.6 Percent	GC-MS	Resolve DOI
Falcarindiol	Roots and other underground parts	Solvent extraction	≤ 6.68 Milligram/gram	High Performance Liquid Chromatography (HPLC)/Liquid Chromatography (LC)	Resolve DOI
Polyacetylene derivatives	Roots and other underground parts	Solvent extraction	—	High Performance Liquid Chromatography (HPLC)/Liquid Chromatography (LC)	Resolve DOI
Coumarins	Roots and other underground parts	Solvent extraction	—	Standard Chromatographic tests (paper- thin layer- and column chromatography)	No resolvable identifier
Lignans	Roots and other underground parts	Solvent extraction	—	Standard Chromatographic tests (paper- thin layer- and column chromatography)	No resolvable identifier
Pentacyclic triterpene saponins	Leaves	Solvent extraction	—	Standard Chromatographic tests (paper- thin layer- and column chromatography)	No resolvable identifier
Phenylpropenoids	Roots and other underground parts	Solvent extraction	—	Standard Chromatographic tests (paper- thin layer- and column chromatography)	No resolvable identifier

Cited sources

The literature the compendium cites for this species. Metatron Health has no relationship with these authors or journals and earns nothing from citing them.

Huang, Weihua., Yang, Jing., Zhao, Jing., Wang, Chong-zhi., Yuan, Chun-su., Li, Shao-ping. Quantitative analysis of six polyynes and one polyene in Oplopanax horridus and Oplopanax elatus by pressurized liquid extraction and on-line SPE-HPLC. JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2010, vol. 53, no. 4, p. 906-910. DOI
Shao, Li., Bao, Mei-Hua., Ouyang, Dong-Sheng., Wang, Chong-Zhi., Yuan, Chun-Su., Zhou, Hong-Hao., Huang, Wei-Hua. Unstable Simple Volatiles and Gas Chromatography-Tandem Mass Spectrometry Analysis of Essential Oil from the Roots Bark of Oplopanax Horridus Extracted by Supercritical Fluid Extraction . Molecules, 2014, vol. 19, no. 12, p. 19708-19717. DOI
Huang, Wei-Hua., Luo, Wei., Wang, Chong-Zhi., Yuan, Chun-Su., Nie, Ming-Kun., Shi, Shu-Yun., Zhou, Hong-Hao., Ouyang, Dong-Sheng. Phenolic constituents from Oplopanax horridus .. Zhongguo zhong yao za zhi = zhongguo zhongyao zazhi = china journal of chinese materia medica, 2014, vol. 39, no. 10, p. 1852-7.
Cao, Kai-yue., Qiao, Chun-feng., Chen, Xian-qiang., Wang, Chong-zhi., Yuan, Chun-su., Zhao, Jing., Li, Shao-ping. Chemical constituents from leaves of oplopanax horridus. Chinese Herbal Medicines, 2014, p. 328-331.

Boundary

A constituent measurement is a fact about material at a stated preparation, not a statement about what that material does in a person. An adverse-effect or genotoxicity record is an observation reported in a source, most often in an animal or laboratory model. Neither is a Metatron Health conclusion about causality, human risk or benefit, and the absence of a record is not proof that a preparation is safe. Nothing here is diagnosis, prescribing or individual medical care.

Continue

Independent literature